30 closest matches · ranked by relevance
Cancer Prevention
Primary: Composite Cancer Screening Tests up to Date — 3087; 2590; 3866 Participants — p=.025
Hypertension · Hypertension in Pregnancy · Diabetes Mellitus
Primary: Rate of Primary Care Provider Visit Attendance — 38; 72 Participants — p=<0.001
Health Risk Appraisal · Heart Disease · Prevention
Primary: Enrollment in Prevention Services — 91; 56 participants — p=<.0001
Fluoride Varnish and Oral Health Promotion · Usual Care
Primary: Evaluation of Decayed, Missing, and Filled Tooth Surfaces (Dmfs) at Baseline — 19.9; 22.8 dmfs
Periodontitis
Primary: Percentage of Participants With Tooth Loss Over 16 Year Period — 16.4; 13.8; 22.1; 16.9 percentage of participants
Human Immunodeficiency Virus (HIV) Positive
Primary: Number of Participants With Viral Load Suppression — 210; 213 Participants — p=0.220
Cardiovascular Disease · Childhood Obesity
Primary: Mean Change in Minutes of Moderate Physical Activity Per Week (From Self Report) Survey — 43.3; 16.8 minutes/week
Behavior · Cardiovascular Risk Factor · Influenza
Primary: Average Take-up of Preventive Services (Post-consultation) — 0.52; .71 score on a scale
Cancer and Chronic Disease Prevention
Primary: Composite Outcome Measure: Mean Percentage of CDPS Actions at Baseline That Are Subsequently Met at Follow-up — 64.5; 42.1 percent of actions
Colorectal Carcinoma
Primary: Change in Screening Metrics — 42; 8; 37; 13 Participants
Diabetes Mellitus
Primary: Number of Incident Diabetes-related ED Visits and/or Hospitalizations — .88; 1.29 Incidence rate ratio — p=.12
Preventive Health Services · Health Communication
Primary: Acceptance of Health Message — 5.5; 5.4 units on a scale — p=0.18
HIV Prevention · HIV Infections
Primary: Retention, Measured as the Number of HIV Exposure Events That Were Retained in Care at the 24 Week Follow-up Visit — 125; 157 HIV Exposure Events — p=<0.05
Human Papillomavirus · Human Immunodeficiency Virus · Hepatitis C
Primary: Percentage of Participants Who Are Screened for All Conditions — 25.18; 8.16; 32.63; 15.79 Percentage of participants
Colorectal Cancer · Breast Cancer · Coronary Heart Disease
Primary: Number of Subjects Who Discussed Disease Risk With Primary Care Provider — 905; 841 Participants
Obesity · Cardiovascular Risk Factor · Eating Behavior
Primary: Change in Bodyweight — -7.4; -6.1 percent weight change — p=0.01
Preterm Birth · Low Birth Weight <2500 Grams · Verylow Birthweight <1500 Grams
Primary: Birthweight — 40; 26 participants
Adolescent Immunizations · Preventive Care
Primary: Receipt of Adolescent Immunization at End of Study Period (Tdap, Menactra, HPV) — 1091; 885; 1783; 1367 participants
Cardiovascular Disease
Primary: Risk of Fatal Coronary Event or Non-fatal MI — 27.0; 26.3 percent risk of major cv event in 10 yrs — p=0.50
Type 2 Diabetes · PreDiabetes
Primary: Body Mass Index (BMI) - Post-Test — 30.3; 28.8 kg/m2
Colorectal Cancer
Primary: FIT Completion — 10.4; 13.9 Model based percentage of participants — p=.05
Fall · Risk Reduction
Primary: Number of Participants With Reported Falls — 37; 34; 29; 24 Participants
Obesity · Obesity, Childhood · Obesity; Familial
Primary: Mother BMI — 30.6; 34.2; 34; 34.3 kg/m^2
Pre-diabetes · Obesity
Primary: Recruitment of Study Participants — 58; 51 Participants
Contraception · Sexually Transmitted Infections · Cervical Cancer
Primary: Identify and Utilization of Primary Care Provider (PCP) — 426; 114; 771 Participants — p=0.624
Cancer, Breast · Cancer, Colon · Cancer, Cervix
Primary: Aim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal Cancers — 85; 85; 85; 85 Participants
Prediabetic State · Obesity · Gestational Diabetes
Primary: Weight Loss — 3.1; 2.8 % of weight loss
Neck Pain
Primary: Neck Pain — 3.8; 3.3; 3.4 cm
Cervical Cancer
Primary: Human Papilloma Virus (HPV) Vaccine #1 Acceptance — 13; 12; 7; 3 Participants
Uterine Cervical Neoplasms · Sexually Transmitted Diseases
Primary: Concordance Between Vaginal Self-swab Results and Provider-collected Cervical Swab Results for HPV DNA Among Sexually Active FTM Adults — 15; 2; 6; 108 Participants…